CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Onyx Therapeutics, Inc. v. Apotex Inc.

1:16-cv-01039

Overview

Case Number 1:16-cv-01039
Filing Date 2016-11-08
Status Terminated
Termination Date 2019-05-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Apotex Corp. Operating Company

Represented By

2 Attorneys Listed

Apotex Corp.

PRO SE

PRO SE

Joseph J. Bellew

White & Williams

Tel: +1 (302) 467-4534
Fax: +1 (302) 467-4540

White & Williams, 600 North King Street, Suite 800

Plaintiff

Onyx Therapeutics, Inc. Operating Company

Represented By

6 Attorneys Listed

Wendy A. Whiteford

Email: wendy@amgen.com

Margaret A. O'Boyle

Email: moboyle@omm.com

Lisa Barons Pensabene

O'Melveny & Myers LLP

Tel: +1 (212) 326-2077
Fax: +1 (212) 326-2061

7 Times Square, Times Square Tower, New York, NY 10036

Brian Kao

UNDELIVERABLE 6/11/2020

UNDELIVERABLE 6/11/2020

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Interested Party

Apotex Inc. Operating Company

Represented By

6 Attorneys Listed

William Blake Coblentz

Email: wcoblentz@cozen.com

Kerry B. McTigue

Email: kmctigue@cozen.com

Eric Choi

UNDELIVERABLE EMAIL 10/21/2020

Barry P. Golob

Email: bgolob@cozen.com

Aaron S. Lukas

Email: alukas@cozen.com

Joseph J. Bellew

White & Williams

Tel: +1 (302) 467-4534
Fax: +1 (302) 467-4540

White & Williams, 600 North King Street, Suite 800

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 4 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (4 found):
U.S. Courts: 4
U.S. District Court 2016-11-08
1:16-cv-01036

Onyx Therapeutics, Inc. v. InnoPharma Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-11-01
1:16-cv-01011

Onyx Therapeutics, Inc. v. Dr. Reddy's Laboratories, Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-10-26
1:16-cv-01000

Onyx Therapeutics, Inc. v. Sagent Pharmaceuticals, Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-10-26
1:16-cv-00999

Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7737112
Composition for enzyme inhibition
Filed: 2005-12-07
Issued: 2010-06-15
Active (1.1 yrs remaining) +742d PTA
Expires: 2027-12-19

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+742 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 5 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for purposes of discovery and all paper...
Entry #24 • 2017-04-18 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (21 in 1:16-cv-01036-LPS, 17 in 1:16-cv-01000-LPS, 18 in 1:16-cv-01013-LPS, 18 in 1:16-cv-01001-LPS, 22 in 1:16-cv-01039-LPS, 25 in 1:16-cv-01012...
Entry #β€” • 2017-03-27
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to March 29, 2017 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Ent...
Entry #22 • 2017-03-22 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer Complaint to January 31, 2017 - filed by Apotex Corp., Apotex Inc.. (Bellew, Joseph) (Entered: 01/31/2017)
Entry #13 • 2017-01-31 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Defendants to Move, Answer or Otherwise Respond to Plaintiff's Complaint to January 30, 2017 filed by Apotex Inc...
Entry #β€” • 2016-11-29
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to Move, Answer or Otherwise Respond to Plaintiff's Complaint to January 30, 2017 - filed by Apotex Corp., Apotex Inc....
Entry #9 • 2016-11-22 Document →

Docket Entries

(60 total)
Pleading / Complaint

COMPLAINT for Patent Infringement filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2027062.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/08/2016)

Entry #1 • 2016-11-08
1
Pleading / Complaint

COMPLAINT for Patent Infringement filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2027062.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/08/2016)

Entry #1 • 2016-11-08
2
Pleading / Complaint

COMPLAINT for Patent Infringement filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2027062.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/08/2016)

Entry #1 • 2016-11-08
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (klc) (Entered: 11/08/2016)

Entry #2 • 2016-11-08
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 27,2016. Date of Expiration of Patent: December 7, 2027.Thirty Month Stay Deadline: 1/20/2020. (klc) (Entered: 11/08/2016)

Entry #3 • 2016-11-08
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc